Hub : Traits

Delta ambulatory time before/after self-admin

Delta ambulatary time in seconds at the first time point of open field before self admin vs after self admin

Tags: Behavior · Heroin · Open field test

Project: u01_peter_kalivas

1 loci · 1 genes with independent associations · 1 total associated genes

Significant Loci

#	Chr	Start pos	End pos	# assoc genes	# joint models	Best TWAS P	Best GWAS P	Cond GWAS P	Joint genes
1	10	62271668	63667097	1	1	1.76e-10	4.45e-02	5.67e-07	Eral1

Pleiotropic Associations

Trait	Chi2 ratio	# genes+	# genes++	% genes++	Corr	Corr P	Genes
Heart weight	3.63	1	0	0	0	1e+00	Eral1
Left kidney weight	1.53	1	0	0	0	1e+00	Eral1
Food consumed during 24 hour testing period	14.68	1	0	0	0	1e+00	Eral1
Times rat made contact with spout	19.64	1	0	0	0	1e+00	Eral1
Mean time between licks in bursts	5.57	1	0	0	0	1e+00	Eral1
Mean num. licks in bursts	16.6	1	0	0	0	1e+00	Eral1
Std. dev. time between licks in bursts	13.88	1	0	0	0	1e+00	Eral1
Intermittent access intake escalation 2	6.45	1	0	0	0	1e+00	Eral1
Intermitt. access day 1 inactive lever presses	5.81	1	0	0	0	1e+00	Eral1
Intermitt. access day 15 inactive lever presses	19.83	1	0	0	0	1e+00	Eral1
Intermittent access total locomotion	7.32	1	0	0	0	1e+00	Eral1
Short access day 10 total inactive lever presses	4.2	1	0	0	0	1e+00	Eral1
Short access day 1 total infusions	28.54	1	1	100	0	1e+00	Eral1
Short access total infusions	17.56	1	0	0	0	1e+00	Eral1
Short access day 1 locomotion	23.22	1	0	0	0	1e+00	Eral1
Short access total locomotion	23.77	1	0	0	0	1e+00	Eral1
Breakpoint value in progressive ratio session	7.34	1	0	0	0	1e+00	Eral1
Distance traveled before self-admin	58.43	1	1	100	0	1e+00	Eral1
Distance traveled after self-admin	7.49	1	0	0	0	1e+00	Eral1
Delta time in open arm before/after self-admin	8.04	1	0	0	0	1e+00	Eral1
Extinction: sum of active levers before priming	8.22	1	0	0	0	1e+00	Eral1
Active lever presses in extinction session 6	20.19	1	0	0	0	1e+00	Eral1
Delta distance traveled before/after self-admin	8.53	1	0	0	0	1e+00	Eral1
Time in open arm after self-admin	10.52	1	0	0	0	1e+00	Eral1
Time to tail flick, vehicle, before self-admin	10.06	1	0	0	0	1e+00	Eral1
Time to tail flick, vehicle, after self-admin	4.88	1	0	0	0	1e+00	Eral1
Ambulatory time before self-admin	49.07	1	1	100	0	1e+00	Eral1
Ambulatory time after self-admin	6.62	1	0	0	0	1e+00	Eral1
Total heroin consumption	3.34	1	0	0	0	1e+00	Eral1
Area under the delay curve	45.55	1	1	100	0	1e+00	Eral1
Delay disc. indifference point, 16s delay	63.86	1	1	100	0	1e+00	Eral1
Delay disc. indifference point, 24s delay	9.47	1	0	0	0	1e+00	Eral1
Delay disc. indifference point, 4s delay	6.47	1	0	0	0	1e+00	Eral1
Delay disc. indifference point, 8s delay	71.89	1	1	100	0	1e+00	Eral1
Delay discount exponential model param	36.26	1	1	100	0	1e+00	Eral1
Delay discount hyperbolic model param	29.71	1	1	100	0	1e+00	Eral1
Rest time, locomotor task time 1	15.21	1	0	0	0	1e+00	Eral1
Distance moved, locomotor task time 1	3.68	1	0	0	0	1e+00	Eral1
Time >=10cm from walls, locomotor time 2	39.82	1	1	100	0	1e+00	Eral1
Rest time, locomotor task time 2	5.56	1	0	0	0	1e+00	Eral1
Distance moved, locomotor task time 2	13.4	1	0	0	0	1e+00	Eral1
Vertical activity count, locomotor time 2	8.68	1	0	0	0	1e+00	Eral1
Weight adjusted by age	3.44	1	0	0	0	1e+00	Eral1
Locomotion in novel chamber post-restriction	13.53	1	0	0	0	1e+00	Eral1
Progressive ratio	27.88	1	1	100	0	1e+00	Eral1
Food seeking constrained by brief footshock	13.98	1	0	0	0	1e+00	Eral1
Seeking ratio, punishment vs. effort	10.23	1	0	0	0	1e+00	Eral1
Run reversals in cocaine runway, males	48.09	1	1	100	0	1e+00	Eral1
Latency to leave start box in cocaine runway	12.57	1	0	0	0	1e+00	Eral1
Latency to leave start box in cocaine runway, M	38.49	1	1	100	0	1e+00	Eral1

Associations by panel

Tissue	RNA modality	# hits	% hits/tests	Avg chisq
Adipose	alternative polyA	0	0	1.1
Adipose	alternative TSS	0	0	1.08
Adipose	gene expression	1	0	1.05
Adipose	isoform ratio	0	0	1.08
Adipose	intron excision ratio	0	0	1.1
Adipose	mRNA stability	0	0	1.07
BLA	alternative polyA	0	0	1.07
BLA	alternative TSS	0	0	1.12
BLA	gene expression	0	0	1.09
BLA	isoform ratio	0	0	1.2
BLA	intron excision ratio	0	0	1.13
BLA	mRNA stability	0	0	1.08
Brain	alternative polyA	0	0	1.05
Brain	alternative TSS	0	0	1.06
Brain	gene expression	0	0	1.08
Brain	isoform ratio	0	0	1.07
Brain	intron excision ratio	0	0	1.13
Brain	mRNA stability	0	0	1.06
Eye	alternative polyA	0	0	1.01
Eye	alternative TSS	0	0	1.06
Eye	gene expression	0	0	1.03
Eye	isoform ratio	0	0	1.17
Eye	intron excision ratio	0	0	1.04
Eye	mRNA stability	0	0	1.08
IL	alternative polyA	0	0	1.07
IL	alternative TSS	0	0	1.02
IL	gene expression	0	0	1.08
IL	isoform ratio	0	0	1.11
IL	intron excision ratio	0	0	1.13
IL	mRNA stability	0	0	1.06
LHb	alternative polyA	0	0	1.05
LHb	alternative TSS	0	0	1.18
LHb	gene expression	0	0	1.11
LHb	isoform ratio	0	0	1.27
LHb	intron excision ratio	0	0	1.1
LHb	mRNA stability	0	0	1.08
Liver	alternative polyA	0	0	1.13
Liver	alternative TSS	0	0	1.04
Liver	gene expression	0	0	1.06
Liver	isoform ratio	0	0	1.21
Liver	intron excision ratio	0	0	1.09
Liver	mRNA stability	0	0	1.05
NAcc	alternative polyA	0	0	1.1
NAcc	alternative TSS	0	0	1.14
NAcc	gene expression	0	0	1.1
NAcc	isoform ratio	0	0	1.12
NAcc	intron excision ratio	0	0	1.12
NAcc	mRNA stability	0	0	1.09
OFC	alternative polyA	0	0	1.14
OFC	alternative TSS	0	0	1.14
OFC	gene expression	0	0	1.08
OFC	isoform ratio	0	0	1.08
OFC	intron excision ratio	0	0	1.04
OFC	mRNA stability	0	0	1.14
PL	alternative polyA	0	0	1.13
PL	alternative TSS	0	0	1.13
PL	gene expression	0	0	1.07
PL	isoform ratio	0	0	1.12
PL	intron excision ratio	0	0	1.09
PL	mRNA stability	0	0	1.06